Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 24 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Liberal glycemic control in critically Ill patients with type 2 diabetes: an exploratory studyKar, P.; Plummer, M.P.; Bellomo, R.; Jenkins, A.J.; Januszewski, A.S.; Chapman, M.J.; Jones, K.L.; Horowitz, M.; Deane, A.M.
2014Glucagon-like peptide 1 attenuates the acceleration of gastric emptying induced by hypoglycemia in healthy subjectsPlummer, M.; Jones, K.; Annink, C.; Cousins, C.; Meier, J.; Chapman, M.; Horowitz, M.; Deane, A.
2019Gastric emptying in patients with well-controlled type 2 diabetes compared with young and older control subjects without diabetesWatson, L.E.; Xie, C.; Wang, X.; Li, Z.; Phillips, L.K.; Sun, Z.; Jones, K.L.; Horowitz, M.; Rayner, C.K.; Wu, T.
2015Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?Wu, T.; Trahair, L.; Bound, M.; Deacon, C.; Horowitz, M.; Rayner, C.; Jones, K.
2013Endothelin-1 and endothelin receptor gene variants and their association with negative outcomes following aneurysmal subarachnoid hemorrhageGallek, M.; Alexander, S.; Crago, E.; Sherwood, P.; Horowitz, M.; Poloyac, S.; Conley, Y.
2015Hyperglycemia potentiates the slowing of gastric emptying induced by exogenous GLP-1Plummer, M.; Jones, K.; Cousins, C.; Trahair, L.; Meier, J.; Chapman, M.; Horowitz, M.; Deane, A.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2013Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetesWu, T.; Bound, M.; Zhao, R.; Standfield, S.; Bellon, M.; Jones, K.; Horowitz, M.; Rayner, C.
2014Effects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, mesenteric blood flow, and glycemic responses to intraduodenal glucose in healthy older subjectsTrahair, L.; Horowitz, M.; Hausken, T.; Feinle-Bisset, C.; Rayner, C.; Jones, K.
2013The effect of exogenous glucose-dependent insulinotropic polypeptide in combination with glucagon-like peptide-1 on glycemia in the critically illLee, M.; Fraser, J.; Chapman, M.; Sundararajan, K.; Umapathysivam, M.; Summers, M.; Zaknic, A.; Rayner, C.; Meier, J.; Horowitz, M.; Deane, A.